Doug Smith is the founder and Managing Director of Village Green Global, a compa...
Mark Jarzombek, associate dean of the Massachusetts Institute of Technology's Sc...
Will someone just say they saw Manbearpig so this douche will go away? I"m super...
Until now, hydro power has been Kenya's largest energy source, but climate chang...
Poul Nyrup Rasmussen, President of the European Socialist Party and former Prime...
Robert H. Lustig, MD, UCSF Professor of Pediatrics in the Division of Endocrinology, explores the da...
http://www.nucleusinc.com This 3D patient education medical animation depicts various surgical proce...
In a new study, researchers at the Moores Cancer Center and Department of Family and Preventive Medi...
Cancer occurs when a single cell in the body stops performing its normal function and grows out of c...
SEE MORE VIDEOS @ www.preop.com Patient Education 617-379-1582 INFO For a female, lubricate the cath...
MedCom |
(0) (0 Votes)
|
Views: (1626) Date: (01-10-09) Time: (00:10:28) |
Description: II clinical trials for Buerger's Disease as well as Osteoarthritis. RNL is a publically traded company on the Korean Stock Exchange (Code 003190) and plans to expand its operations throughout the world. For questions regarding the press conference or receiving stem cell therapy, please contact, Jin Han Hong, at hongjh@rnl.co.kr ... "Adult stem cell" "Stem Cell" "Stem Cell Therapy" "stem cell tourism" arthritis Antiaging "Liver Cirrhosis" "Renal Failure" Osteoarthritis Parkinson Alzheimer ...